BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog
Giannoukakis, N.
Current Opinion in Investigational Drugs 8(10): 842-848
2007
ISSN/ISBN: 1472-4472 PMID: 17907061 Document Number: 607793
F Hoffmann-La Roche Ltd, Teijin Ltd and Chugai Pharmaceutical Co Ltd, under license from Ipsen, are developing the glucagon-like peptide 1 analog BIM-51077, for the potential treatment of type 2 diabetes. Phase II clinical trials are underway, including a phase II trial evaluating a slow release formulation.
Document emailed within 1 workday
Related Documents
Wei, P.; Yang, Y.; Li, T.; Ding, Q.; Sun, H. 2015: A engineered Bifidobacterium longum secreting a bioative penetratin-Glucagon-like peptide 1 fusion protein enhances Glucagon-like peptide 1 absorption in the intestine Journal of Microbiology and Biotechnology 2015Küllertz, G.; Fischer, G.; Barth, A. 1978: Catalytic mechanism of dipeptidyl-peptidase IV Acta Biologica et Medica Germanica 37(4): 559-567
Sedo, A.; Kraml, J. 1994: Dipeptidyl peptidase IV in cell proliferation and differentiation Sbornik Lekarsky 95(4): 285-288
Küllertz, G.; Barth, A.; Fischer, G. 1986: Determination of dipeptidyl-peptidase IV in biological materials Journal of Clinical Chemistry and Clinical Biochemistry 24(8): 551-558
Heymann, E.; Mentlein, R.; Nausch, I.; Erlanson-Albertsson, C.; Yoshimoto, T.; Feller, A.C. 1986: Processing of pro-colipase and trypsinogen by pancreatic dipeptidyl peptidase IV Biomedica Biochimica Acta 45(5): 575-584
Sanda, M.G.; Pierson, R.; Smith, C.; Reemtsma, K.; Rose, E. 1989: Serum dipeptidyl peptidase IV in cardiac transplant recipients Transplantation Proceedings 21(1 Part 3): 2525-2526
Sedo, A.; Malík, R.; Drbal, K.; Lisá, V.; Vlasicová, K.; Mares, V. 2001: Dipeptidyl peptidase IV in two human glioma cell lines European Journal of Histochemistry: Ejh 45(1): 57-63
Komatsu, M.; Urade, M.; Yamaoka, M.; Fukasawa, K.; Harada, M. 1987: Alteration in dipeptidyl peptidase activities in cultured human carcinoma cells Journal of the National Cancer Institute 78(5): 863-868
Krepela, E.; Kraml, J.; Vicar, J.; Kadlecová, L.; Kasafírek, E. 1983: Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum Physiologia Bohemoslovaca 32(6): 486-496
Wang, S.-C.; Zeng, L.-L.; Ding, Y.-Y.; Zeng, S.-G.; Song, H.-R.; Hu, W.-H.; Xie, H. 2014: A novel dipeptidyl peptidase IV inhibitors developed through scaffold hopping and drug splicing strategy Yao Xue Xue Bao 49(1): 61-67
Natori, Y.; Hayakawa, I.; Shibata, S. 1987: Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV Clinical and Experimental Immunology 70(2): 434-439
Kalra, S. 2011: Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes Journal of the Association of Physicians of India 59: 237-245
Mest, H.-J. 2006: Dipeptidyl peptidase-IV inhibitors can restore glucose homeostasis in type 2 diabetics via incretin enhancement Current Opinion in Investigational Drugs 7(4): 338-343
Simaga, S.; Babić, D.; Osmak, M.; Sprem, M.; Abramić, M. 2003: Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas Gynecologic Oncology 91(1): 194-200
Harland, C.; Shah, T.; Webster, A.D.; Peters, T.J. 1988: Dipeptidyl peptidase IV--subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood Clinical and Experimental Immunology 74(2): 201-205
Cuchacovich, M.; Gatica, H.; Pizzo, S.V.; Gonzalez-Gronow, M. 2001: Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases Clinical and Experimental Rheumatology 19(6): 673-680
Xu, J. 2004: Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. Dipeptidyl peptidase-IV inhibitors 26-27 July 2004, San Diego, CA, USA IDrugs: the investigational drugs journal 7(9): 839-840
Kandeel, M.; Elaiziz, M.A.; Kandeel, A.; Altaher, A.A.; Kitade, Y. 2014: Association of host tropism of Middle East syndrome coronavirus with the amino acid structure of host cell receptor dipeptidyl peptidase 4 Acta Virologica 58(4): 359-363
Ellingsen, T.; Hansen, I.; Thorsen, J.; Kuno Møller, B.; Tarp, U.; Jacobsen, S.; Lund Hetland, M.; Vestergaard, A.; Hørslev-Petersen, K.; Stengaard-Pedersen, K. 2012: Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis Clinical and Experimental Rheumatology 30(1): 58-63
Fontana, J.; Červinková, Z.; Anděl, M. 2013: Effects of GLP-1 (glucagon-like peptide 1) on liver Vnitrni Lekarstvi 59(7): 551-558